Patients who come to UCLA benefit from the most advanced forms of cancer care available.  They also have access to a full range of supportive services.

Teams of specialists work together to treat and assist cancer patients and their families. This multidisciplinary approach helps patients and family members confront both the immediate and long-term effects of cancer.

UCLA’s Jonsson Comprehensive Cancer Center (JCCC) has been designated a “comprehensive cancer center” by the National Cancer Institute, a testament to its excellence not only in patient care, but also in cancer research, education and community outreach in cancer prevention.

Why choose cancer care at UCLA?

• A Comprehensive Cancer Center: Patients benefit from a full range of care and support services from doctors, clinics, centers and hospitals crossing over 40 scientific and medical disciplines. JCCC is consistently ranked by U.S. News & World Reports as the best cancer center in California, and one of the top ten in the U.S.
• UCLA: A world-class medical center integrated with a research and teaching university, UCLA is consistently ranked by U.S. News & World Reports as the best medical center in the western United States and one of the best three hospitals in the country.  More than 100 UCLA physicians are listed among the Best Doctors in America.
• The Most Advanced Treatment: JCCC has established an international reputation for developing new cancer therapies, providing the best in experimental and traditional treatments. Successful targeted therapies such as Herceptin, Gleevec, and Sprycel were developed based on basic science performed in UCLA laboratories and clinical trials with UCLA patients.
• An Interdisciplinary Approach: More than 350 of our physicians and scientists work across areas such as immunology, genetics, geriatrics, hematology, public health, dentistry and nursing to provide patients with comprehensive yet specialized treatment.
• More Than Treatment: Patients have access to a full range of services, including early detection, prevention, education, wellness, nutritional guidance, survivorship and psychological support.
• Collaboration: Close collaboration between researchers and physicians leads to scientific discoveries and improved cancer detection, prevention and treatment for patients.
• Many Locations: Clinics, centers and hospitals are located in Westwood, Santa Monica, Alhambra, Irvine, Pasadena, Porter Ranch, Santa Clarita and Simi Valley. Clinical trials are offered across California and the United States.

For men experiencing problems with urination, erectile dysfunction, incontinence, infertility or other prostate or genitourinary problems, help can be found within the Center for Male Urology.

The Department of Urology at UCLA is one of the oldest, most progressive and comprehensive urology programs in the country. Faculty members within the UCLA Department of Urology have been on the forefront of developing new treatments and cures for male urological problems for over half a century. These include:

• Benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate that affects at least 50 percent of American males over the age of 50. BPH is often associated with a higher incidence of lower urinary tract symptoms. New treatments that rely more on drug therapies and less on surgery have helped the advance treatments available for BPH at UCLA.
• Infertility, defined as the failure of a couple to conceive within one year of intercourse without contraception. About half of all cases of infertility are due to factors in the male, such as problems with sperm production, blockages of the vessels that deliver sperm, hormonal disorders, and problems within the testicle itself. Specialists at UCLA utilize the new methods of testing and treatment for issues affecting sperm quality and quantity.
• Erectile dysfunction (ED), defined as the inability for a man to achieve and maintain penile erection for satisfactory sexual activity. About 10 percent of all men will experience difficulty in attaining or maintaining an erection at some point in their lives. Jacob Rajfer, M.D. was actively involved in the research that led to the development of Viagra, which was related to his research on the role of nitric oxide in getting and maintaining an erection. Urologists at UCLA continue to be at the forefront of developing new tests and treatments for ED.

Nationally Acknowledged Excellence

The Prostate Cancer Program at UCLA is a nationally acknowledged center of excellence as designated by the National Cancer Institute, which awarded it the Specialized Program of Research Excellence (SPORE) designation in 2002—one of only 11 in the country.  The state of California has acknowledged UCLA’s leadership in the fight against prostate cancer by awarding the Jonsson Comprehensive Cancer Center and the UCLA Department of Urology contracts totaling more than $89 million to administer IMPACT, a statewide prostate cancer awareness and treatment program targeting uninsured and underinsured men.

Innovative Research

UCLA urologists have developed less invasive treatments for benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate. Research conducted by some of our noted faculty members helped lead to the development of Viagra, the most advanced treatment to date for erectile dysfunction.

Find a doctor

http://www.uclahealth.org/body.cfm?id=479

*Source: National Cancer Institute; Jonsson Comprehensive Cancer Center UCLA